List prices for prescription drugs have gone through the roof even though net prices have declined.Īnd despite this increase in healthcare costs, life expectancy has remained stagnant. Today, health care premiums have increased faster than inflation. Welcome to today’s hearing on the role of Pharmacy Benefit Managers in Pharmaceutical Markets. In addition to the PBM Committee report released in 2021, Chairman Comer stressed that the Committee will press forward to shine a light on PBMs undermining health practices, harming community pharmacies, and prioritizing their pocketbooks over patients.īelow are Chairman Comer’s remarks as prepared for delivery. State legislatures across the country have passed legislation preventing some of their anticompetitive practices and Chairman Comer stressed that Congress also has a responsibility to act. Today, three large PBMs collectively control approximately 80 percent of the health market and engage in self-benefitting practices that boost their bottom line without a benefit to patients. He highlighted how Pharmacy Benefit Managers’ (PBMs) deliberate, anticompetitive tactics aim to prevent payers-including government payers like Medicare, Medicaid, TRICARE, and the Federal Employee Health Benefits program-from understanding how PBMs are making billions at the expense of patients and taxpayers. WASHINGTON – Today, House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) delivered opening remarks at a full committee hearing titled “The Role of Pharmacy Benefit Managers In Prescription Drug Markets Part I: Self-Interest Or Health Care?” In his opening statement, Chairman Comer emphasized that Americans are suffering from rising health care premiums and expensive prescription drug prices.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |